A detailed history of Csenge Advisory Group transactions in Metlife Inc stock. As of the latest transaction made, Csenge Advisory Group holds 12,421 shares of MET stock, worth $1.02 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,421
Previous 12,757 2.63%
Holding current value
$1.02 Million
Previous $895,000 14.41%
% of portfolio
0.05%
Previous 0.05%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$67.96 - $82.48 $22,834 - $27,713
-336 Reduced 2.63%
12,421 $1.02 Million
Q2 2024

Jul 10, 2024

SELL
$68.55 - $74.22 $20,290 - $21,969
-296 Reduced 2.27%
12,757 $895,000
Q1 2024

May 03, 2024

BUY
$65.35 - $74.11 $24,440 - $27,717
374 Added 2.95%
13,053 $967,000
Q4 2023

Feb 13, 2024

BUY
$58.29 - $66.9 $26,230 - $30,105
450 Added 3.68%
12,679 $838,000
Q3 2023

Nov 01, 2023

SELL
$56.71 - $66.36 $95,669 - $111,949
-1,687 Reduced 12.12%
12,229 $769,000
Q2 2023

Jul 20, 2023

BUY
$49.12 - $61.81 $41,506 - $52,229
845 Added 6.46%
13,916 $786,000
Q1 2023

May 01, 2023

SELL
$54.3 - $73.58 $207,263 - $280,854
-3,817 Reduced 22.6%
13,071 $757,000
Q4 2022

Feb 10, 2023

BUY
$62.62 - $76.95 $5,823 - $7,156
93 Added 0.55%
16,888 $1.22 Million
Q3 2022

Oct 04, 2022

SELL
$22.01 - $68.52 $31,738 - $98,805
-1,442 Reduced 7.91%
16,795 $1.02 Million
Q2 2022

Jul 27, 2022

SELL
$60.87 - $72.44 $7,913 - $9,417
-130 Reduced 0.71%
18,237 $1.15 Million
Q1 2022

May 09, 2022

SELL
$61.96 - $71.63 $146,845 - $169,763
-2,370 Reduced 11.43%
18,367 $1.29 Million
Q4 2021

Feb 10, 2022

SELL
$57.11 - $66.6 $10,736 - $12,520
-188 Reduced 0.9%
20,737 $1.26 Million
Q3 2021

Oct 20, 2021

BUY
$55.86 - $63.61 $10,501 - $11,958
188 Added 0.91%
20,925 $1.31 Million
Q2 2021

Jul 21, 2021

BUY
$58.3 - $67.16 $502,837 - $579,255
8,625 Added 71.21%
20,737 $1.26 Million
Q1 2021

Apr 28, 2021

BUY
$46.08 - $61.76 $192,890 - $258,527
4,186 Added 52.81%
12,112 $750,000
Q4 2020

Jan 26, 2021

BUY
$36.6 - $48.67 $34,184 - $45,457
934 Added 13.36%
7,926 $372,000
Q3 2020

Nov 09, 2020

SELL
$35.39 - $40.57 $562,417 - $644,738
-15,892 Reduced 69.45%
6,992 $268,000
Q2 2020

Jul 17, 2020

BUY
$27.72 - $43.0 $228,523 - $354,492
8,244 Added 56.31%
22,884 $836,000
Q1 2020

Apr 21, 2020

BUY
$23.53 - $52.61 $49,860 - $111,480
2,119 Added 16.92%
14,640 $448,000
Q4 2019

Feb 05, 2020

BUY
$43.83 - $51.36 $149,504 - $175,188
3,411 Added 37.44%
12,521 $638,000
Q3 2019

Nov 14, 2019

SELL
$43.71 - $50.92 $80,994 - $94,354
-1,853 Reduced 16.9%
9,110 $429,000
Q2 2019

Jul 30, 2019

BUY
$43.93 - $49.67 $481,604 - $544,532
10,963 New
10,963 $544,000
Q4 2018

Feb 07, 2019

SELL
$38.24 - $47.77 $4,053 - $5,063
-106 Closed
0 $0
Q3 2018

Nov 19, 2018

BUY
$43.4 - $48.79 $4,600 - $5,171
106 New
106 $4,000

Others Institutions Holding MET

About METLIFE INC


  • Ticker MET
  • Exchange NYSE
  • Sector Financial Services
  • Industry Insurance—Life
  • Shares Outstandng 797,614,016
  • Market Cap $65.6B
  • Description
  • MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...
More about MET
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.